Abnormal Biomarkers of Homocysteine Metabolism in Neonates with Conotruncal Heart Defects
Open Access
- 27 July 2017
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-5
Abstract
Objectives. The etiology of conotruncal heart defects (CHD) remains unknown; however relation between homocysteine, folate levels, and congenital heart disease was found. With this perspective in mind, the aim of the study was to investigate biomarkers of homosyteine metabolism pathway in mothers and their neonates with CHD.Material and Methods. Forty-three pairs of mothers and their neonates with CHD and forty pairs of mothers and neonates with nonconotruncal heart defects (non-CHD) were enrolled. The control group (CG) consisted of fifty-nine pairs of mothers and their healthy neonates. For estimating the plasma total homocysteine (tHcy), serum folates, and cobalamin levels, mothers’ venous blood samples and umbilical cord blood were taken in all groups.Results. We observed higher tHcy levels in newborns with CHD in comparison to their mothers and to neonates with non-CHD. Cobalamin levels were significantly lower in neonates with CHD compared to other children. Folates and cobalamin levels were lower in CHD mothers compared to their children.Conclusions. Elevated homocysteine levels in neonates with CHD and folate metabolism disturbances in their mothers were noticed. The observed differences in homocysteine and cobalamin levels between neonates with CHD suggest the influence of various agents disturbing homocysteine metabolic pathways.Keywords
This publication has 21 references indexed in Scilit:
- Maternal and offspring methylenetetrahydrofolate reductase gene C677T polymorphism: does it influence the prevalence of congenital heart defects in Egyptian neonates?Comparative Clinical Pathology, 2012
- Functional Variant in Methionine Synthase Reductase Intron-1 Significantly Increases the Risk of Congenital Heart Disease in the Han Chinese PopulationCirculation, 2012
- The Prevalence of Congenital Anomalies in Europe2010
- Expression of folate transporters in human placenta and implications for homocysteine metabolismPlacenta, 2010
- Maternal Global Methylation Status and Risk of Congenital Heart DiseasesObstetrics & Gynecology, 2008
- Maternal hyperhomocysteinaemia is a risk factor for congenital heart diseaseBJOG: An International Journal of Obstetrics & Gynaecology, 2006
- The impact of metabolism on DNA methylationHuman Molecular Genetics, 2005
- Folic acid and homocysteine affect neural crest and neuroepithelial cell outgrowth and differentiation in vitroDevelopmental Dynamics, 2003
- Occurrence of Congenital Heart Defects in Relation to Maternal Multivitamin UseAmerican Journal of Epidemiology, 2000
- Prevention of neural tube defects: Results of the Medical Research Council Vitamin StudyThe Lancet, 1991